9 November 2017
Current warnings November 2017
Since the beginning of November 2017, we have tested a number of substances of particular health concern. In addition to the expected active ingredient MDMA, one tablet sold as ecstasy contained a unknown substance identified. In addition to MDMA, another ecstasy tablet contained the new psychoactive substance Methylone (3,4-methylenedioxymethcathinone, bk-MDMA) on. In addition to the expected amphetamine, a sample given as speed also contained caffeine and the hallucinogenic substance 2C-E (2,5-dimethoxy-4-ethylphenethylamine).